CEPHALON INC (NASDAQ: CEPH)

View Portfolio
Back to Investopedia
Back to Investopedia




$65.78 0.78 (1.20%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
80.24
52-Week Low Price
52.55
Avg Volume (3 Mo.)
1.00 M
Market Cap
4.85 B
P/E Ratio (TTM)
19.7
Diluted EPS (TTM)
5.96
Shares
74.66 M
Dividend Rate ($) / (%)
0.00/0.00
79%
21%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -18% - CEPH has underperformed the S&P 500 by 44%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
HOSPIRA INC (HSP) $49.42 -  $0.66(1.35%)7.87 B
VERTEX PHARMACEUTICALS (VRTX) $37.90 -  $0.48(1.28%)6.82 B
WARNER CHILCOTT A (WCRX) $25.51 -  $0.30(1.19%)6.42 B
SIGMA-ALDRICH CORP (SIAL) $48.25 -  $1.46(3.12%)5.78 B
MYLAN INC (MYL) $17.68 -  $0.08(0.45%)5.47 B
QIAGEN NV (QGEN) $20.60 -  $0.06(0.29%)4.81 B
HUMAN GENOME SCIENCES (HGSI) $27.06 -  $1.30(5.05%)4.41 B
PERRIGO CO (PRGO) $46.32 -  $0.58(1.27%)4.13 B
ALEXION PHARMACEUTICALS (ALXN) $46.91 -  $0.94(2.04%)4.14 B
WATSON PHARMACEUTICALS (WPI) $38.10 -  $0.41(1.09%)4.05 B
As of February 09, 2010 at 5:45 PM ET
STOCK ANALYSIS
Stock Analysis
Four Stocks Seeking A Rebound (CEPH, CIT, HNSN, ISRG, MYGN)
Four stocks coming off of new 52-week lows and looking to bounce back.
Stock Analysis
A Rising Tide Does Not Lift All Boats (KEY, PBCT, GME, PHM, CEPH)
The market had its best quarterky return since 1998, but not all stocks participated in this rebound.
Stock Analysis
Companies That Are Beating Earnings Estimates (HD)
Companies that have exceeded earnings estimates are worthy of further research as analysts' ratings might boost sto...
Stock Analysis
Five Cash Flow Kings For August 18 (SLE)
Cash flow analysis can put the fortunes of a company into an entirely new light. This week features Sara Lee.
Stock Analysis
Five Stocks That Are Defying Market Conditions (TYC, AZN, CEPH)
Not all companies are missing earnings - some are even beating earnings and raising guidance.
View All Stock Analysis
CEPH RELATED HEADLINES
arrow
Bears Wary of Cephalon, Inc.'s Recent Rally
Yesterday, S&P Equity Research raised Cephalon's (CEPH: sentiment, chart, options) price target by $5 to $77 and reiterated its "buy" rating, after the company said its acquisition of Mepha AG would be immediately accretive to its 2010 earnings per share...(Read More)
By SchaeffersResearch 2/2/2010
arrow
Cephalon (CEPH) Showing Bullish Technicals With Support At 63.58
Cephalon (NASDAQ: CEPH) closed yesterday at $64.93. So far the stock has hit a 52-week low of $52.55 and 52-week high of $81.35. Cephalon stock has been showing support around 63.58 and resistance in the 65.80 range. Technical indicators for the stock are Bullish and S&P gives CEPH a positive 4 STAR (out of 5) buy rating. CEPH appears on the Investors Observer Momentum Plays list. For a hedged play on this stock, look at a May '10 60 covered call for a net debit in the $57.33 area. That is also the break even stock price for this trade. This covered call has an 115 day duration, provides 11.70% do...
At Market Intelligence Center 1/28/2010
arrow
The Pharma Marketing Hydra
Just because academic centers limit how much drug companies pay doctors doesn't mean high-paid speakers will go away.
Forbes.com 1/28/2010
arrow
Cephalon (CEPH) Appearing On Investors Observer Momentum Plays List
Cephalon (NASDAQ: CEPH) closed yesterday at $64.00. So far the stock has hit a 52-week low of $52.55 and 52-week high of $81.35. Cephalon stock has been showing support around 62.67 and resistance in the 64.91 range. Technical indicators for the stock are Bullish and S&P gives CEPH a positive 4 STAR (out of 5) buy rating. CEPH appears on the Investors Observer Momentum Plays list. For a hedged play on this stock, look at a May '10 60 covered call for a net debit in the $57.20 area. That is also the break even stock price for this trade. This covered call has a 128 day duration, provides 10.63% d...
At Market Intelligence Center 1/14/2010
arrow
Options trader looks for Cephalon shares to recover from mixed drug trial data
Shares of Cephalon Inc. (CEPH: sentiment, chart, options) have plummeted nearly 10% today, after the company announced mixed results in a Cinquil trial...(Read More)
By SchaeffersResearch 11/23/2009
arrow
Cephalon (CEPH) NewsBite - CEPH Falls on Disappointing Drug Study Results
Cephalon (NasdaqNM: CEPH) opened at $54.87. So far today, the stock has hit a low of $53.71 and a high of $55.00. CEPH is now trading at $54.73, down $4.88 (-8.19%). Over the last 52 weeks the stock has ranged from a low of $52.55 to a high of $81.35. CEPH shares are falling this morning after the company said a late-stage study on Cinquil, its experimental drug to treat to treat pediatric eosinophilic esophagitis, showed d...
At Market Intelligence Center 11/23/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1